VEGZELMA Trademark

Trademark Overview

On Thursday, August 13, 2020, a trademark application was filed for VEGZELMA with the United States Patent and Trademark Office. The USPTO has given the VEGZELMA trademark a serial number of 79294361. The federal status of this trademark filing is REGISTERED as of Tuesday, March 23, 2021. This trademark is owned by CELLTRION, INC.. The VEGZELMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer; antibodies for medical purposes for the treatment of cancer
vegzelma

General Information

Serial Number79294361
Word MarkVEGZELMA
Filing DateThursday, August 13, 2020
Status700 - REGISTERED
Status DateTuesday, March 23, 2021
Registration Number6297705
Registration DateTuesday, March 23, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 5, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer; antibodies for medical purposes for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 28, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCELLTRION, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR
Party NameCELLTRION, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR
Party NameCELLTRION, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events

Event DateEvent Description
Friday, November 5, 2021NEW REPRESENTATIVE AT IB RECEIVED
Monday, July 19, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, June 30, 2021FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, June 30, 2021FINAL DISPOSITION PROCESSED
Wednesday, June 23, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 23, 2021REGISTERED-PRINCIPAL REGISTER
Monday, January 11, 2021NOTIFICATION PROCESSED BY IB
Tuesday, January 5, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 5, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 23, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 23, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, December 6, 2020REFUSAL PROCESSED BY IB
Friday, December 4, 2020NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, December 1, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 25, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 24, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 24, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 24, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 24, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 24, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 24, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 24, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 17, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, November 17, 2020REFUSAL PROCESSED BY MPU
Wednesday, October 28, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, October 27, 2020NON-FINAL ACTION WRITTEN
Tuesday, October 20, 2020ASSIGNED TO EXAMINER
Friday, October 2, 2020APPLICATION FILING RECEIPT MAILED
Monday, September 28, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 24, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

vegzelma treatment cancer purposes medical antibodies pharmaceutical preparations